Concepedia

Tommy Smith

TS

4

Publications

531

Citations

4

H-Index

1986

Active since

Affiliations

Eli Lilly (United States)(Current)

Tommy Smith is an author at Eli Lilly (United States) specializing in medicine, drug discovery, and drug development.

Top concepts

MedicineThrombosisPharmacologyDrug DiscoveryPharmacotherapyDrug DevelopmentMedicinal ChemistryHealthDiabetesHematology

Publications per year

1986–2003

4

Publications

4

Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development.

F. Arthur McMorris, Tommy Smith, Stephanie DeSalvo et al. · Proceedings of the National Academy of Sciences · 1986 · 387 citations · Full text

Human Growth, Igf-i Concentration, Igf Deficiency +18

Engineering the proteolytic specificity of activated protein C improves its pharmacological properties

David T. Berg, Bruce Gerlitz, Tommy Smith et al. · Proceedings of the National Academy of Sciences · 2003 · 58 citations · Full text

Structure-Based Design of Potent, Amidine-Derived Inhibitors of Factor Xa: Evaluation of Selectivity, Anticoagulant Activity, and Antithrombotic Activity

Michael R. Wiley, Leonard C. Weir, Steven L. Briggs et al. · Journal of Medicinal Chemistry · 2000 · 46 citations

Drug Target, Pharmacotherapy, Amidine-derived Inhibitors +20

Non-Amidine-Containing 1,2-Dibenzamidobenzene Inhibitors of Human Factor Xa with Potent Anticoagulant and Antithrombotic Activity

John J. Masters, Jeffry B. Franciskovich, Jennifer M. Tinsley et al. · Journal of Medicinal Chemistry · 2000 · 40 citations

Altmetric Attention Score, Pharmacotherapy, Translational Pharmacology +19

Rows per page

1–4 of 4